Research projects
Cima Universidad de Navarra
-
Tumor Evasion and New TargetsActive
Inmunoterapia génica personalizada basada en AAVs para el tratamiento del cáncer de páncreas (IMMUNAAV)
Cima Principal Investigator: Juan Dubrot Armendáriz -
Hepatology: Carcinogenesis and Liquid BiopsyActive
Characterisation of the therapeutic potential of the SLU7-TAZ-AREG axis in liver cancer (SLUTAREG)
Cima Principal Investigator: Carmen Berasain Lasarte -
Gene Therapy in Neurological DiseasesActive
Restoring Lipid Homeostasis in Neurodegeneration: From Fundamental Mechanisms to Therapeutic Translation
Cima Principal Investigator: Ana Mª García Osta -
Immune TherapiesActive
Development of HLA-independent T cells redirected by nanoantibodies as a new therapeutic strategy for multiple myeloma. HINT4MM
Cima Principal Investigator: Juan Roberto Rodríguez Madoz -
Radioimmunotherapy strategies for pediatric tumorsActive
Study of neuroimmune interactions to prevent radiotherapy-induced cognitive impairment in paediatric brain tumours. (NeuroImmunePed)
Cima Principal Investigator: Sara Labiano Almiñana -
Hepatology: Metabolism, Epigenetics and CarcinogenesisActive
New epigenetic mechanisms and therapeutic strategies in cholangiocarcinoma. EPICHOL
Cima Principal Investigator: Matías Ávila Zaragozá -
Immunomodulation and Tumor MicroenvironmentActive
Understanding the tumour microenvironment for the optimised development of immunotherapies
Cima Principal Investigator: Juan José Lasarte -
Renal Gene Therapy and Chimeric AAV DevelopmentActive
Engineering of AAV Vectors for Gene Therapy to Treat Polycystic Kidney Disease: Adaptation to Disease Progression. (AAV-PKD)
Cima Principal Investigator: Rafael Aldabe Arregui -
Hepatology: Diagnosis and Therapeutic ResponseActive
Study of the molecular mechanisms and development of diagnostic strategies for the management of patients with liver cancer
Cima Principal Investigator: María Arechederra CalderónFunder: Ministerio de Ciencia, Innovación y UniversidadesAward year 2025 -
Intracavitary ImmunotherapyActive
Modified Immunocytokine mRNAs Targeting the Omentum as a New Locoregional Immunotherapy for Peritoneal Metastases
Cima Principal Investigator: Fernando Aranda VegaFunder: Ministerio de Ciencia, Innovación y UniversidadesAward year 2026